NextCure Receives $67,000,000 Series A Financing

  • Feed Type
  • Date
    1/7/2016
  • Company Name
    NextCure
  • Mailing Address
    Undisclosed New Haven, CT 06501 USA
  • Company Description
    NextCure, launched in 2015, is a biopharmaceutical company focused on discovering and developing next generation immuno-oncology-based drugs. The Company is applying its proprietary platforms and know-how to identify novel and biologically relevant targets and develop first-in-class immunotherapy products.
  • Website
    http://www.nextcure.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $67,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Canaan Partners
  • Venture Investor
    Lilly Asia Ventures
  • Venture Investor
    OrbiMed
  • Venture Investor
    Pfizer Venture Investments
  • Venture Investor
    Sofinnova Ventures
  • Venture Investor
    Alexandria Venture Investments

Trending on Xconomy